HRID548513

反应详情

EQUATION

反应方程式

HRID 548513 的结构方程式

AUXILIARIES

试剂、催化剂与溶剂

1

PROCEDURE

实验过程

M-PEOZ-O—CH2—CO2—NHS (M-PEOZ-SCM 5000) (180 mg, 0.034 mmol) was dissolved in 11 mL of pyridine and added to a solution of cytosine arabinose (Ara-C) (5.7 mg, 0.023 mmol), previously dissolved in 5 mL of anhydrous pyridine at 0° C. The resulting solution stirred for 72 hours at room temperature. Reverse phase HPLC (C-18 column) showed that reaction was complete. After evaporation of the solvent, the product was dissolved in methylene chloride (5 mL) and added drop by drop into 150 mL ether. The precipitate was collected by centrifugation at 4° C. and dried under vacuum. Yield 150 mg, 80%. NMR showed the usual peaks of the M-PEOZ backbone (above) plus the pyrimidine protons of Ara-C at 7.31, 7.67, 8.16, and 8.62 ppm. Exposure of the conjugate to pH 8 buffer showed that Ara-C is slowly released (15% after 24 hours), so the conjugate can be regarded as a prodrug.

WORKUP

后处理

  1. customReverse phase HPLC (C-18 column) showed that reaction
  2. customAfter evaporation of the solvent
  3. dissolutionthe product was dissolved in methylene chloride (5 mL)
  4. additionadded drop by drop into 150 mL ether
  5. customThe precipitate was collected by centrifugation at 4° C.
  6. customdried under vacuum
  7. custom(15% after 24 hours)